Product
Zabdeno
1 clinical trial
1 indication
Indication
EbolaClinical trial
Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC: a Mix-and-match Phase II RCTStatus: Not yet recruiting, Estimated PCD: 2025-10-01